Clinical Lymphatic Mapping in Gynecologic Cancers Second Edition PDF

1 The history of lymphatic mapping: a gynecologic perspective 1 Charles F. Levenback 2 Lymphatic anatomy: microanatomy and physiology 9 Erin K. Crane and Charles F. Levenback 3 Lymphatic anatomy: lymphatics of the vulva . 15 Anca Chelariu-Raicu and Robert L. Coleman 4 Lymphatic anatomy: lymphatics of the cervix 23 Anca Chelariu-Raicu and Katherine C. Kurnit 5 Lymphatic anatomy: lymphatics of the uterus 29 Jennifer J. Mueller and Nadeem R. Abu-Rustum 6 Lymphatic anatomy: lymphatics of the ovary . 35 Ate G.J. van der Zee 7 Lymphatic anatomy: lymphatics of the breast and axilla 39 James V. Fiorica 8 Modalities of detection of sentinel nodes in lymphatic mapping. 43 Blanca Segarra, Nuria Agusti, and Pedro T. Ramirez 9 Ultrastaging of the sentinel node 55 Celien P.H. Vreuls, Ate G.J. van der Zee, and Paul J. van Diest 10 Sentinel lymph node biopsy of the vulva 65 Maaike Oonk and Ate G.J. van der Zee 11 Sentinel lymph node mapping in cervical cancer . 71 David Cibula and Martina Borcinova 12 Sentinel lymph node mapping in breast cancer 83 Angelena Crown and Mary L. Gemignani 13 Sentinel lymph node biopsy of the endometrium 99 Jennifer J. Mueller and Nadeem R. Abu-Rustum 14 Impact of sentinel lymph node mapping on quality of life111 Mariana Antonella Nigra, Pedro T. Ramirez, and Larissa Meyer 15 Radiation oncology considerations 117 Gwendolyn Joyce McGinnis and Anuja Jhingran…
Clinical Lymphatic Mapping in Gynecologic Cancers Second Edition PDF Ebook

Charles Levenback, MD is Professor and Deputy Chairman, Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA, and formerly Chief Professionalism Officer. In 2017 he shared the Society of Gynecologic Oncology Innovation Award in recognition for his role in the development of sentinel lymph node biopsy in gynecologic oncology patients and his lead investigator role in multiple institutional and national clinical trials.
Ate G.J. van der Zee, MD, PhD is Professor of Gynaecological Oncology and Vice President of the Board of Directors, University Medical Center Groningen, The Netherlands. He leads a world-wide consortium (GROINSS-V-II), which performs landmark clinical studies in vulvar cancer, and shared the SGO Innovation Award in 2017.
Robert L. Coleman, MD, FACOG, FACS is Chief Scientific Officer, US Oncology Research, The US Oncology Network, McKesson Specialty Health, The Woodlands, TX, USA, and formerly Professor and Ann Rife Cox Chair of the Department of Gynecologic Oncology and Reproductive Medicine at the University of Texas MD Anderson Cancer Center and Executive Director of Cancer Network Research.